Диссертация (1140289), страница 20
Текст из файла (страница 20)
Clerico // American journal ofOtolaryngology Head and Neck Medicine and Surgery/ -2014/ - V/35/ Is.3. –P.300-304236.Choi J.Y. Symptomatic SUNCT syndrome associated with ipsilateralparanasal sinusitis / J.Y. Choi [et al.] // Headache. 2008. – Vol.48(10)/ P/1527-1530237.Cheng Y.K. Increased prevalence of interleukin – 1 receptorantagonist gene polymorphism in patients with chronic rhinosinusitis / Y.K.Cheng, C.D. Lin, W.C. Chang [et al.] // Arch. Otolaryngol. Head. Neck.Surg.
– 2006. –№ 132(3). – P. 285-290238.Chiu I.M. Bacteria activate sensory neurons that modulate pain andflammation / I.M. Chiu et al.// Nature. – 2013. - №501. P.52-57239.Costa S. K. Pivotal role of endogenous tachykinis and the NK 1 re-ceptor in mediating leukocyte accumulation, in the absence of oedemeformation, in response to TNF alpha in the cutaneous microvasculature / S.K.Costa, L.
M. Yshii, R.N. Poston [et al.] // J.Neuroimmunol. – 2006/ Vol.171. – P.99-109240.Linden M., Greiff L., Sjidersson M. et al. Nasal Cytokines in commoncold and allergic rhinitis Clin. Exp. Allergy. – 1995. – Vol.25. – № 2.- P.166172241.Lundberg J.O.N. Airborne nitric oxide: Inflammatonymorker andaerocrine in man. Acta Physiol Scand 1995; 157: Suppl 633142242.McMahon S.B. Crosstalk between the nociceptive and immunesystems in host defence and disease / S.B.McMahon,F.L.Russa,D.L.Bennett D.L. // Nat. Rev.
Neurosci. 2015. Vol.16. N.17. P. 389-402243.Mazza J.M. Primary immunodeficiency and recalcitrant chronicsinusitis: asystematic review / J.M. Mazza., S.Y. Lin // Int Forum AllergyRhinol. 2016. Vol.6. № 10. P.1029-1033244.Medzhitov R., Janeway C.A. Jr. Innate immunity: impact on theadaptive immune response. Curr. Opin.
Immunol. – 1997.9. 4-9245.Halderman A. Genetic and Immune Dysregulation in ChronicRhinosinusitis /A. Halderman, Lane A.P. // Otolaryngol Clin North Am .2017. Vol.50. N.1. P.13-28246.Hood V.C. Differential role of neurokinin receptors in humanlymphocyte and monocyte chemotaxis / V.C.
Hood, S.C. Cruwys, L. Urban,B.L. Kidd // Regul. Pept. – 2000. - № 96. – P.17-21247.Oppenheim J. Cytokine Reference / J. Oppenheim, M.Feldmann. –Academic Press, London, 2000. – 2015pp248.Roseler S., Holtappels G., Wagenmann M., Bachert C. Elevated levesof interleukins IL-1 beta, IL-6 and IL-8 in naturally acguired viral ninis //Eur. Arch. Arhinolaryngol. Suppl.- 1995.- Vol 1.- P.61-63249.Ren K.
Role of interleukin 1β during pain and inflammation / K.Ren,R. Torres // Brain Research Reviews. 2009. Vol. 60. N.1. P.57-64250.Rosenfeld R.M. Clinical practice guideline: adult sinusitis / Andes D.,Bhattacharyya N. et al. // Otolaryngol Head Neck Surg. 2007. Vol. 137. P.131251.Rudack C. Cytokines in nasal polyposis, acute and chronic sinusitis /C. Rudack, N.Stoll, C. Bachert // Am. J.Rhinol.- 1998.
– Vol. 12.- №6.- P.383-388252.Suzuki A., Suko T., Sakamoto N., Mogi G. Clinical features andcharacteristies of paranasal sinus effusion in allergic sinusitis // NipponJibinkoka Gakkai kaiho. – 1999. – Vol. 101. - №6. – P.821-828143253.Tenovuo J. Nonimmunoglobulin defense factors in human saliva.Human Saliva: Clinical chemistry and Microbiology. Boca Raton, CRC PressInc 1998; 2: 55-78254.Thomson A. (Ed.) The Cytokine Handboock.
London: Acad. Press.,1992, P.418255.Tsabouri S. Omalizumab for the Treatment of Inadeguately ControlledAllergic Rhinitis: A Systematic Review and Meta-Analysis of RandomizedClinical Trials / S.Tsabouri, X. Tseretopoulou, K. Priftis, E.A.Ntzani // J. ofAllergy and Clinical Immunology. 2014.
Vol.2. Is.3. P. 332-340256.Waldmann T.A. The IL-2 recep for system: a target for rationalimmune intervention. Immunol Today, 14: 264-270, 1993.